Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19
COVID19 is the designated name given by the WHO for the corona virus disease caused by the virus SARS-COV-2 that was initially identified in the late 2019 and progressed to be a world pandemic.Patients with COVID-19 may have a wide range of coagulation abnormalities (in the direction of an underlyin...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of TURAZ AKADEMI
2020-12-01
|
Series: | Medicine Science |
Subjects: | |
Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=105941 |
id |
doaj-6482180dccf34b5e81ca5a6dcd8b4ea7 |
---|---|
record_format |
Article |
spelling |
doaj-6482180dccf34b5e81ca5a6dcd8b4ea72021-03-24T11:50:49ZengSociety of TURAZ AKADEMI Medicine Science2147-06342020-12-01941097910.5455/medscience.2020.05.084105941Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19Mohammed Talaat Rashid0Waleed Askar1Ahmed Gaafar2Mohamed Fawzy3Mahmoud Abul makarem4Emergency Medicine Department, Saudi German Hospital, Madina. General Surgery Department, Saudi German Hospital, Madina. Emergency Medicine Department, Saudi German Hospital, Madina. Radiology department, Saudi German Hospital, Madina. General Surgery Department, Saudi German Hospital, MadinaCOVID19 is the designated name given by the WHO for the corona virus disease caused by the virus SARS-COV-2 that was initially identified in the late 2019 and progressed to be a world pandemic.Patients with COVID-19 may have a wide range of coagulation abnormalities (in the direction of an underlying hypercoagulable state), raising questions about appropriate evaluations and interventions to prevent or treat thrombosis. Hypercoagulable state associated with COVID-19 has been repeatedly reported. The prevalence of venous thromboembolism is increasing, especially in the critically ill patient in spite of prophylactic use of anticoagulation. [1-3]. Arterial thrombosis has also been reported but the prevalence is not known. [3]. In this case report, we present a 37 years old man who suffered an acute abdomen due to superior mesenteric artery thrombosis as a possible complication of the COVID-19. [Med-Science 2020; 9(4.000): 1097-9]http://www.ejmanager.com/fulltextpdf.php?mno=105941covid-19superior mesenteric artery thrombosisacute abdomenhypercoagulability |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mohammed Talaat Rashid Waleed Askar Ahmed Gaafar Mohamed Fawzy Mahmoud Abul makarem |
spellingShingle |
Mohammed Talaat Rashid Waleed Askar Ahmed Gaafar Mohamed Fawzy Mahmoud Abul makarem Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19 Medicine Science covid-19 superior mesenteric artery thrombosis acute abdomen hypercoagulability |
author_facet |
Mohammed Talaat Rashid Waleed Askar Ahmed Gaafar Mohamed Fawzy Mahmoud Abul makarem |
author_sort |
Mohammed Talaat Rashid |
title |
Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19 |
title_short |
Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19 |
title_full |
Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19 |
title_fullStr |
Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19 |
title_full_unstemmed |
Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19 |
title_sort |
superior mesenteric artery thrombosis as a possible presenting complication of covid-19 |
publisher |
Society of TURAZ AKADEMI |
series |
Medicine Science |
issn |
2147-0634 |
publishDate |
2020-12-01 |
description |
COVID19 is the designated name given by the WHO for the corona virus disease caused by the virus SARS-COV-2 that was initially identified in the late 2019 and progressed to be a world pandemic.Patients with COVID-19 may have a wide range of coagulation abnormalities (in the direction of an underlying hypercoagulable state), raising questions about appropriate evaluations and interventions to prevent or treat thrombosis. Hypercoagulable state associated with COVID-19 has been repeatedly reported. The prevalence of venous thromboembolism is increasing, especially in the critically ill patient in spite of prophylactic use of anticoagulation. [1-3]. Arterial thrombosis has also been reported but the prevalence is not known. [3]. In this case report, we present a 37 years old man who suffered an acute abdomen due to superior mesenteric artery thrombosis as a possible complication of the COVID-19. [Med-Science 2020; 9(4.000): 1097-9] |
topic |
covid-19 superior mesenteric artery thrombosis acute abdomen hypercoagulability |
url |
http://www.ejmanager.com/fulltextpdf.php?mno=105941 |
work_keys_str_mv |
AT mohammedtalaatrashid superiormesentericarterythrombosisasapossiblepresentingcomplicationofcovid19 AT waleedaskar superiormesentericarterythrombosisasapossiblepresentingcomplicationofcovid19 AT ahmedgaafar superiormesentericarterythrombosisasapossiblepresentingcomplicationofcovid19 AT mohamedfawzy superiormesentericarterythrombosisasapossiblepresentingcomplicationofcovid19 AT mahmoudabulmakarem superiormesentericarterythrombosisasapossiblepresentingcomplicationofcovid19 |
_version_ |
1724204889705283584 |